Lanie Lindenfeld

Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children’s Oncology Group

Kristin R. Knight, Lu Chen, David R. Freyer et al. · Journal of Clinical Oncology · 2017 · 86 citations · Full text

Rationale and design of the Children’s Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure

Saro H. Armenian, Melissa M. Hudson, Ming Hui Chen et al. · BMC Cardiovascular Disorders · 2016 · 38 citations · Full text

Effect of carvedilol versus placebo on cardiac function in anthracycline-exposed survivors of childhood cancer (PREVENT-HF): a randomised, controlled, phase 2b trial

Saro H. Armenian, Melissa M. Hudson, Lanie Lindenfeld et al. · The Lancet Oncology · 2024 · 33 citations · Full text

Cardiovascular Disease, Medicine, Phase 2B +9

Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell Transplant

June‐Wha Rhee, Raju Pillai, Tianhui He et al. · JAMA Cardiology · 2023 · 28 citations · Full text

Accuracy of a Novel Handheld Wireless Platform for Detection of Cardiac Dysfunction in Anthracycline-Exposed Survivors of Childhood Cancer

Saro H. Armenian, Derek Rinderknecht, Kaylene Au et al. · Clinical Cancer Research · 2018 · 21 citations